Results for tag: "Tropisetron"

Tropisetron is an antiemetic drug used in the treatment of nausea and vomiting caused by chemotherapy and radiotherapy in oncology patients. It is a 5-HT3 receptor antagonist, meaning it blocks the action of serotonin, a neurotransmitter that can cause nausea and vomiting. Tropisetron is available in oral and intravenous formulations, and is often used in combination with other antiemetics. It is generally well tolerated, with few side effects. Tropisetron is used in the treatment of a variety of cancers, including breast, lung, and colorectal cancer. It is also used to treat nausea and vomiting caused by other treatments, such as radiation therapy. It is often used in combination with other antiemetics, such as dexamethasone and ondansetron. Some companies in the Tropisetron market include GlaxoSmithKline, Merck, Sanofi, and Teva Pharmaceuticals. Show Less Read more